Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook

Go back to Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook

Abbott (ABT) slips as results, guidance barely meet consensus

January 24, 2024 7:47 AM EST

Abbott (NYSE: ABT) reported fourth-quarter results that met average analyst estimates. Shares fell 2% in response to the released figures.

Adjusted earnings per share (EPS) of $1.19 and revenue of $10.24 billion were in line with the market consensus.

"The strength and diversity of the... More

Abbott (ABT) Reports In-Line Q4 EPS, Offers Guidance

January 24, 2024 7:31 AM EST

Abbott (NYSE: ABT) reported Q4 EPS of $1.19, in-line with the analyst estimate of $1.19. Revenue for the quarter came in at $10.24 billion versus the consensus estimate of $10.17 billion.

GUIDANCE:

Abbott sees FY2024 EPS of $4.50-$4.70, versus the consensus of $4.63.

For earnings history and earnings-related data on Abbott (ABT) click here.

... More